BioArctic AB
STO:BIOA B

Watchlist Manager
BioArctic AB Logo
BioArctic AB
STO:BIOA B
Watchlist
Price: 202 SEK -5.08% Market Closed
Market Cap: 17.8B SEK
Have any thoughts about
BioArctic AB?
Write Note

P/S
Price to Sales

106.8
Current
85
Median
7.6
Industry
Higher than median
Higher than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S
106.8
=
Market Cap
17.9B SEK
/
Revenue
167.1m SEK
All Countries
Close
Market Cap P/S
SE
BioArctic AB
STO:BIOA B
17.9B SEK 106.8
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 134 846.2
US
Abbvie Inc
NYSE:ABBV
318.1B USD 5.7
US
Amgen Inc
NASDAQ:AMGN
142.2B USD 4.4
US
Gilead Sciences Inc
NASDAQ:GILD
117.1B USD 4.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.2B USD 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 847.4
AU
CSL Ltd
ASX:CSL
135.7B AUD 5.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.7B USD 5.7
US
Seagen Inc
F:SGT
39.3B EUR 17.8
NL
argenx SE
XBRU:ARGX
36.2B EUR 19.3
Revenue Growth P/S to Growth
SE
BioArctic AB
STO:BIOA B
Average P/S: 3 466 988.5
106.8
161%
0.7
FR
Pharnext SCA
OTC:PNEXF
38 134 846.2
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.7
20%
0.3
US
Amgen Inc
NASDAQ:AMGN
4.4
26%
0.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.1
10%
0.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.9
34%
0.3
US
E
Epizyme Inc
F:EPE
1 847.4
N/A N/A
AU
CSL Ltd
ASX:CSL
5.7
23%
0.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.7
23%
0.2
US
S
Seagen Inc
F:SGT
17.8
118%
0.2
NL
argenx SE
XBRU:ARGX
19.3
220%
0.1

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/S
62.9
2-Years Forward
P/S
18.4
3-Years Forward
P/S
11.1

See Also

Discover More